SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,852.90 -876.37
( -1.17%)

Global Indices

Nasdaq

51,986.54 -36.87
(-0.07%)

Dow Jones

7,712.39 31.95
(0.42%)

Hang Seng

63,869.15 -1,047.55
(-1.61%)

Nikkei 225

10,765.28 -116.62
(-1.07%)

Forex

USD-INR

94.77 -0.08
(-0.08%)

EUR-INR

106.47 0.12
(0.11%)

GBP-INR

126.26 0.54
(0.43%)

JPY-INR

0.60 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.0629905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

47.2

13420.69

EPS(TTM)

Face Value()

Div & Yield %

27.18

0.59

Back

Hindustan Oil Exploration Company consolidated net profit declines 84.81% in the March 2026 quarter

Jun 12,2026

Net profit of Hindustan Oil Exploration Company declined 84.81% to Rs 7.77 crore in the quarter ended March 2026 as against Rs 51.16 crore during the previous quarter ended March 2025. Sales reported to Rs -205.89 crore in the quarter ended March 2026 as against Rs 43.39 crore during the previous quarter ended March 2025.

For the full year,net profit declined 57.37% to Rs 62.75 crore in the year ended March 2026 as against Rs 147.21 crore during the previous year ended March 2025. Sales declined 37.47% to Rs 263.15 crore in the year ended March 2026 as against Rs 420.87 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	-205.89	43.39	PL	263.15	420.87	-37
OPM %	-12.93	11.02	-	41.34	41.08	-
PBDT	29.19	57.29	-49	107.43	227.57	-53
PBT	9.01	35.58	-75	32.05	149.95	-79
NP	7.77	51.16	-85	62.75	147.21	-57

73,852.90 -876.37 ( -1.17%)

51,986.54 -36.87 (-0.07%)

7,712.39 31.95 (0.42%)

63,869.15 -1,047.55 (-1.61%)

10,765.28 -116.62 (-1.07%)

94.77 -0.08 (-0.08%)

106.47 0.12 (0.11%)

126.26 0.54 (0.43%)

0.60 0.00 (-0.12%)